Latest period
$114M
YoY change
+303.2%
5Y CAGR
+11.2%
Peak year (FY2013)
$88M
Latest annual
$78.3M
Total Assets history chart for SELLAS Life Sciences Group (SLS) from 2016 to 2025
Latest: $78.3M
Total Assets growth chart for SELLAS Life Sciences Group (SLS) from 2016 to 2025
Latest: +303.2%
Total Assets history table for SELLAS Life Sciences Group (SLS) from 2006 to 2025
| FY2025 | $78.3M | +303.2% | +$58.9M | ||
| FY2024 | $19.4M | +212.5% | +$13.2M | ||
| FY2023 | $6.22M | -70.3% | -$14.7M | ||
| FY2022 | $20.9M | -20.8% | -$5.48M | ||
| FY2021 | $26.4M | -42.6% | -$19.6M | ||
| FY2020 | $46M | +177.3% | +$29.4M | ||
| FY2019 | $16.6M | -1.8% | -$306K | ||
| FY2018 | $16.9M | -49.5% | -$16.6M | ||
| FY2017 | $33.5M | -49.1% | -$32.3M | ||
| FY2016 | $65.8M | -19.9% | -$16.3M | ||
| FY2015 | $82.1M | +2.1% | +$1.66M | ||
| FY2014 | $80.5M | -8.5% | -$7.49M | ||
| FY2013 | $88M | +60.0% | +$33M | ||
| FY2012 | $55M | +77.6% | +$24M | ||
| FY2011 | $31M | +314.2% | +$23.5M | ||
| FY2010 | $7.48M | +19.6% | +$1.22M | ||
| FY2009 | $6.25M | -39.6% | -$4.11M | ||
| FY2008 | $10.4M | -14.7% | -$1.79M | ||
| FY2007 | $12.1M | +607250.0% | +$12.1M | ||
| FY2006 | $2K | — | — |
- FY2025$78.3M+303.2%
- FY2024$19.4M+212.5%
- FY2023$6.22M-70.3%
- FY2022$20.9M-20.8%
- FY2021$26.4M-42.6%
- FY2020$46M+177.3%
- FY2019$16.6M-1.8%
- FY2018$16.9M-49.5%
- FY2017$33.5M-49.1%
- FY2016$65.8M-19.9%
- FY2015$82.1M+2.1%
- FY2014$80.5M-8.5%
- FY2013$88M+60.0%
- FY2012$55M+77.6%
- FY2011$31M+314.2%
- FY2010$7.48M+19.6%
- FY2009$6.25M-39.6%
- FY2008$10.4M-14.7%
- FY2007$12.1M+607250.0%
- FY2006$2K—
Total Assets values are taken from SELLAS Life Sciences Group's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Assets at SELLAS Life Sciences Group (SLS)
According to SELLAS Life Sciences Group's latest reported financial statements, the company's latest reported total assets is $114M. Total assets sum everything the company reports owning at the end of each reporting period — cash, receivables, inventory, property, plant, equipment, intangibles, and other holdings — as filed on the balance sheet. Compare with total liabilities and total equity for the capital-structure picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of SELLAS Life Sciences Group (SLS) total assets is $78.3M – surged 303.2% year-over-year.
Over 2020–2025 (5 years), SELLAS Life Sciences Group total assets expanded at a +11.2% compound annual rate, sustaining 2 straight years of year-over-year growth.
Between 2013 and 2025, SELLAS Life Sciences Group total assets declined 10.9%, falling from $88M to $78.3M.
Across the available history, total assets reached its high of $88M in 2013 and its low of $2K in 2006.
SELLAS Life Sciences Group Total Assets by Year
SELLAS Life Sciences Group Total Assets 2025: $78.3M
2025's total assets for SELLAS Life Sciences Group came in at $78.3M, surged 303.2% from 2024.
SELLAS Life Sciences Group Total Assets 2024: $19.4M
SELLAS Life Sciences Group posted total assets of $19.4M in 2024, surged 212.5% from 2023.
SELLAS Life Sciences Group Total Assets 2023: $6.22M
In 2023, SELLAS Life Sciences Group reported total assets of $6.22M, plunged 70.3% below 2022.
SELLAS Life Sciences Group Total Assets 2022: $20.9M
SELLAS Life Sciences Group total assets in 2022 was $20.9M, declined 20.8% below 2021.
SELLAS Life Sciences Group Total Assets 2021: $26.4M
SELLAS Life Sciences Group total assets in 2021 was $26.4M.
See more financial history for SELLAS Life Sciences Group (SLS).
Sector peers by Total Assets
Healthcare peers of SELLAS Life Sciences Group (SLS), ranked by their latest total assets
| $310B | |
| $199B | |
| $137B | |
| $134B | |
| $112B | |
| $110B | |
| $90.6B | |
| $85.4B |
- $137B
- $134B
- $112B
- $90.6B
- $85.4B
Frequently asked questions
Test yourself on SLS
Market Cap — 10 rounds, every one of them SLS against another company. Leave whenever you like.
Practice run — it doesn’t move your skill rating and doesn’t touch the leaderboards. Misses do go into your review queue.
SELLAS Life Sciences Group (SLS) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.